Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001052736 | SCV001216961 | uncertain significance | RASopathy | 2019-04-06 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with SOS1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with arginine at codon 1178 of the SOS1 protein (p.Ser1178Arg). The serine residue is highly conserved and there is a moderate physicochemical difference between serine and arginine. |
Gene |
RCV001759789 | SCV001985187 | uncertain significance | not provided | 2021-04-09 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Genome- |
RCV002468126 | SCV002763562 | uncertain significance | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002468125 | SCV002763563 | uncertain significance | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing |